Connection

Solange Peters to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications Solange Peters has written about Antineoplastic Combined Chemotherapy Protocols.
Solange Peters
Connection Strength
0.570
Antineoplastic Combined Chemotherapy Protocols
  1. Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial. J Thorac Oncol. 2017 04; 12(4):752-762.
    View in: PubMed
    Score: 0.313
  2. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2019 11 21; 381(21):2020-2031.
    View in: PubMed
    Score: 0.095
  3. Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer. N Engl J Med. 2017 11 16; 377(20):1986-1988.
    View in: PubMed
    Score: 0.083
  4. Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respir Med. 2017 05; 5(5):435-444.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.